9229.T

The company's capital structure is characterized by a high debt-to-equity ratio of 2.61, indicating a significant reliance on debt financing. The liquidity position is moderate, with a current ratio of 1.78, suggesting the company has enough current assets to cover its current liabilities, but not with a large buffer. The company's free cash flow is negative at -3996000000.0 JPY, which may indicate that the company is investing heavily in its operations or facing operational challenges.

Profitability metrics show a negative return on equity of -0.1074 and a negative return on assets of -0.0237, indicating that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is 410000000.0 JPY, but the net income is negative at -925000000.0 JPY, which suggests that the company is experiencing losses after accounting for all expenses.

The company's revenue is concentrated in the healthcare sector, with no specific segments or geographic regions disclosed. The lack of detailed segment information makes it difficult to assess the company's exposure to different markets or product lines.

The company's growth trajectory is uncertain, as the financial data does not provide specific outlooks for the current or next fiscal year. The negative net income and high debt levels may pose challenges to the company's growth and financial stability.

The company faces several risk factors, including a medium liquidity risk and a negative free cash flow, which could impact its ability to meet short-term obligations. The dilution potential is low, but the company's high debt-to-equity ratio may increase the risk of dilution if it needs to raise additional capital.

Recent events and filings do not provide specific details about the company's operations or financial performance. The company's financial snapshot indicates a negative net income and a high debt burden, which may be of concern to investors.